| Literature DB >> 35800594 |
Santosha Kumar Pattashanee1, Gopal Puri1, Kamal Kataria1, Piyush Ranjan1, Anita Dhar1, Anurag Srivastava1, Surabhi Vyas2, Yashdeep Gupta3, R M Pandey4.
Abstract
Objectives: This is a diagnostic test research study to evaluate the various existing methods of thyroid examination and their comparison with the novel modified Rose method. It also aims to measure inter-examiner variation in clinical findings based on the level of education and training, as compared to ultrasonography. Methodology: This cross-sectional study was conducted at a tertiary care hospital with 83 patients presenting to surgery OPD with neck swelling. Each patient was examined by one trained Junior Resident and a Surgery Consultant with all the four methods and with ultrasonography. Data was analysed by Stata-14, agreement between the two categorical variables was assessed by Kappa. In case of continuous variable agreement was assessed by Intra class correlation and Bland-Altman plot.Entities:
Keywords: Kappa statistic; clinical thyroid examination; modified Rose method; modified Rose position; retro-sternal extension
Year: 2022 PMID: 35800594 PMCID: PMC9242661 DOI: 10.15605/jafes.037.01.02
Source DB: PubMed Journal: J ASEAN Fed Endocr Soc ISSN: 0857-1074
Figure 1Positioning the patient for Modified Rose’s Method. The yellow arrow shows the hyperextended neck, and the black double arrow shows the necessary elevation of shoulder blades should be 10-12 cm. This can be achieved by a shoulder roll or a pillow.
Figure 2Examination by Modified Rose’s method for a solitary thyroid nodule. (A) Head is turned to the side of palpation; (B) palpating the right lobe; (C) measurement by Vernier callipers; (D) palpating the left lobe; (E) palpating the lower border; (F) palpating the lower border on swallowing. Caution while palpating (G) thyroid gland, (H) sternocleidomastoid muscle may be mistaken as thyroid gland substance.
Agreement for various parameters between USG and clinical methods; Consultant (C) and Resident (R)
| Parameter Assessed | Lahey’s (n=83) | Pizzilo’s (n=83) | Crile’s (n=52 C & n=56 R) | Modified Rose (n=83) | |||||
|---|---|---|---|---|---|---|---|---|---|
| C | R | C | R | C | R | C | R | ||
| Nodularity | Agreement % | 80.72% | 77.10% | 81.93% | 78.31% | 86.54% | 83.98% | 93.98% | 86.75% |
| Cohen’s Kappa (95% CI) | 0.73 | 0.68 | 0.75 | 0.70 | 0.79 | 0.76 | 0.91 | 0.81 | |
| (0.60-0.85) | (0.56-0.79) | (0.63-0.87) | (0.57-0.82) | (0.62-0.95) | (0.60-0.91) | (0.78-1.03) | (0.68-0.93) | ||
| P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
| Consistency | Agreement % | 26.90% | 44.30% | 26% | 40% | 17% | 19% | 59.50% | 37% |
| Cohen’s Kappa (95% CI) | 0.20 | 0.23 | 0.21 | 0.20 | 0.08 | 0.11 | 0.40 | 0.49 | |
| (0.10-0.30) | (0.12-0.34) | (0.11-0.31) | (0.10-0.30) | (0.02-0.18) | (0.01-0.21) | (0.20-0.57) | (0.36-0.62) | ||
| P value | <0.001 | <0.001 | <0.001 | <0.001 | 0.05 | 0.01 | <0.001 | <0.001 | |
| Lymph Node palpability | Agreement % | 90.36% | 92.77% | 90.36% | 90.30% | 88.46% | 90.09% | 87.95% | 90.36% |
| Cohen’s Kappa (95% CI) | 0.58 | 0.70 | 0.58 | 0.58 | 0.55 | 0.58 | 0.50 | 0.61 | |
| (0.43-0.73) | (0.55-0.84) | (0.43-0.73) | (0.43-0.72) | (0.35-0.74) | (0.39-0.76) | (0.35-0.65) | (0.45-0.74) | ||
| P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
Mean difference of size (vertical dimension) by various methods and intraclass correlation by consultant and resident
| Cranio-caudal Dimensions (Mean±SD cm) | Consultant | Resident | |||
|---|---|---|---|---|---|
| Right Lobe (n=66) | left lobe (n=47) | Right lobe (n=66) | left lobe (n=47) | ||
| Lahey’s | 3.82±1.42 | 3.45±1.78 | 4.01±1.84 | 3.53±1.89 | |
| Pizzilo’s | 3.9±1.48 | 3.66±1.75 | 4.1±1.89 | 3.73±1.77 | |
| Crile’s | 3.75±1.32 (n=34) | 3.66±1.85 (n=18) | 3.54±1.41 (n=36) | 3.73±2.05 (n=26) | |
| Modified Rose | 4.31±1.76 | 3.74±1.78 | 4.47±2.0 | 3.95±1.96 | |
| Lahey-Rose | Difference of mean (95% CI) | -0.46 (-0.69, -0.24) | -0.51 (-0.80, -0.23) | -0.46 (-0.69, -0.24) | -0.61 (-0.92, -0.31) |
| ICC | 0.94 | 0.95 | 0.94 | 0.93 | |
| Pizzilo-Rose | Difference of mean (95% CI) | -0.24 (-0.40, -0.09) | -0.32 (-0.54, -0.11) | -0.29 (-0.49, -0.08) | -0.41 (-0.62, -0.19) |
| ICC | 0.96 | 0.96 | 0.94 | 0.95 | |
| Crile-Rose | Difference of mean (95% CI) | -0.25 (-0.39, -0.10) | -0.22 (-0.46, 0.02) | -0.27 (-0.54, 0.01) | -0.33 (-0.55, -0.11) |
| ICC | 0.96 | 0.98 | 0.91 | 0.97 | |
Figure 4Bland-Altman plot for agreement between craniocaudal dimension measured by the consultant using the (A) Lahey’s method vs Modified Rose’s method; (B) Pizzilo’s method and Modified Rose’s method.
Diagnostic test indices for finding Solitary Thyroid Nodule (STN) with USG as a gold standard for Consultant (C) and Resident (R)
| STN | Lahey’s (n=83) | Pizzilo’s (n=83) | Crile’s (n=52 C & n=56 R) | Modified Rose (n=83) | ||||
|---|---|---|---|---|---|---|---|---|
| C | R | C | R | C | R | C | R | |
| Sensitivity (95% CI) | 94% | 92.10% | 94% | 94.70% | 97% | 100% | 94% | 86.80% |
| (82.70-98.50) | (79.20-97.20) | (82.70-98.54) | (82.70-98.50) | (85.80-99.50) | (90.30-100) | (82.70-98.50) | (72.60-94.20) | |
| Specificity (95% CI) | 84% | 82.20 | 86% | 80% | 75% | 70% | 100% | 95.50% |
| (71.20-92.20) | (68.70-90.70) | (73.80-93.70) | (66.10-89.10) | (50.50-89.80) | (48-85.45) | (92.10-100) | (85.10-98.70) | |
| PPV (95% CI) | 83% | 81.40% | 85% | 80% | 89% | 85.7% | 100% | 94.20% |
| (70-91.80) | (67.30-90.20) | (72.10-93.20) | (66.10-89.10) | (76.40-95.90) | (72.10-93.20) | (90.30-100) | (81.30-98.40) | |
| NPV (95% CI) | 95% | 92.50% | 95% | 94.70% | 92% | 100% | 95% | 89.50% |
| (83.50-98.60) | (80.14-97.42) | (83.80-98.60) | (82.70-98.50) | (66.60-98.60) | (78.40-100) | (85.70-98.80) | (77.80-95.40) | |
| Diagnostic Accuracy (95% CI) | 89% | 86.70% | 90% | 86.70% | 90% | 89.2% | 97% | 91.50% |
| (80.60-94.10) | (77.80-92.40) | (82.10-95) | (77.80-92.40) | (79.30-95.80) | (78.50-95) | (91.60-99.30) | (83.60-95.80) | |
| Diagnostic Odds (95% CI) | 97 | 53.9 | 117 | 72 | 105 | Not defined | Not defined | 141 |
| (19-501) | (13.20-219.90) | (22-617) | (14.50-365) | (10.60-1034) | (25.80-777) | |||
| Cohen’s kappa (95% CI) | 0.78 | 0.73 | 0.80 | 0.73 | 0.76 | 0.75 | 0.95 | 0.82 |
| (0.57-0.99) | (0.52-0.94) | (0.59-1.00) | (0.52-0.94) | (0.49-1.00) | (0.49-1.00) | (0.73-1.00) | (0.61-1.00) | |
| P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Diagnostic test indices for finding Multinodular Goitre (MNG) with USG as a gold standard for Consultant (C) and Resident (R)
| MNG | Lahey’s (n=83) | Pizzilo’s (n=83) | Crile’s (n=52 C & n=56 R) | Modified Rose (n=83) | ||||
|---|---|---|---|---|---|---|---|---|
| C | R | C | R | C | R | C | R | |
| Sensitivity (95% CI) | 66% | 60.60% | 69% | 60.60% | 66% | 56.20% | 100% | 90.90% |
| (49.60-80.20) | (43.60-75.30) | (52.60-82.60) | (43.60-75.30) | (39-86.10) | (33.10-76.90) | (89.50-100) | (76.40-96.80) | |
| Specificity (95% CI) | 100% | 98% | 100% | 96% | 97% | 100% | 96% | 94% |
| (92.80-100) | (89.50-99.60) | (92.80-100) | (86.50-98.90) | (87.10-99.50) | (91.80-100%) | (86.50-98.90) | (83.70-97.90) | |
| PPV (95% CI) | 100% | 95.20% | 100% | 90.90% | 88% | 100% | 94% | 90.90% |
| (85.10-100) | (77.30-99.10) | (85.60-100) | (72.10-97.40) | (56.50-90) | (70-100) | (81.30-98.40) | (76.40-96.80) | |
| NPV (95% CI) | 81% | 79% | 83% | 78.60% | 90% | 86% | 100% | 94% |
| (70.50-89.60) | (67.30-87.30) | (71.90-90.60) | (66.80-87.10) | (79.30-95.80) | (73.80-93) | (92.50-100) | (83.70-97.90) | |
| Diagnostic Accuracy (95% CI) | 86% | 83.10% | 87% | 81.90% | 90% | 88.10% | 97% | 92.70% |
| (77.80-92.40) | (73.60-89.60) | (79.20-93.30) | (72.30-88.70) | (79.30-95.82) | (77.40-94.10) | (91.60-99.30) | (85.10-96.60) | |
| Diagnostic Odds (95% CI) | Not defined | 75.30% | Not defined | 36.90 | 78 | Not defined | Not defined | 156 |
| (9.20-615) | (7.60-178) | (7.60-793) | (29.60-827) | |||||
| Cohen’s kappa (95% CI) | 0.70 | 0.62 | 0.73 | 0.60 | 0.70 | 0.65 | 0.95 | 0.84 |
| (0.50-0.91) | (0.42-0.82) | (0.52-0.94) | (0.39-0.80) | (0.43-0.97) | (0.41-0.89) | (0.73-1.00) | (0.63-1.00) | |
| P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Diagnostic test indices for palpability of lower border with CT as gold standard for Consultant (C) and Resident (R)
| Lower Border | Lahey’s (n=83) | Pizzilo’s (n=83) | Crile’s (n=52 C & n=56 R) | Modified Rose (n=83) | ||||
|---|---|---|---|---|---|---|---|---|
| C | R | C | R | C | R | C | R | |
| Sensitivity (95% CI) | 77% | 76% | 87% | 85% | 77% | 82% | 98% | 98% |
| (66.40-85.60) | (64.90-84.80) | (77.60-93.20) | (75.90-92.00) | (63.40-86.60) | (69.20-90.20) | (92.40-99.70) | (92.40-99.70) | |
| Specificity (95% CI) | 83% | 83% | 58% | 75% | 75% | 80% | 75% | 66% |
| (55.20-95.30) | (55.20-95.30) | (31.90-80.60) | (46.70-91.10) | (30.06-95.44) | (37.50-96.30) | (46.70-91.10) | (39.00-86.19) | |
| PPV (95% CI) | 38% | 37% | 43% | 47% | 21% | 30% | 90% | 88% |
| (22.40-57.40) | (21.50-55.70) | (23.10-66.80) | (27.30-68.20) | (7.57-47.50) | (12.60-57.60) | (59.50-98.20) | (56.50-98.10) | |
| NPV (95% CI) | 96% | 96% | 92% | 95% | 97% | 97% | 95% | 94% |
| (88-99.30) | (87.80-99) | (83.60-96.70) | (87.10-98.30) | (86.50-99.50) | (87.60-99.50) | (88.26-98.10) | (86.90-97.80) | |
| LR+ (95% CI) | 4.64 | 4.50 | 2.09 | 3.40 | 3.08 | 4.10 | 3.94 | 2.95 |
| (1.73-12.50) | (1.69-12.30) | (1.41-3.11) | (1.70- 6.66) | (0.43- 22.24) | (0.57-29.4) | (2.05-7.50) | (1.81-4.83) | |
| LR- (95% CI) | 0.27 | 0.28 | 0.21 | 0.18 | 0.30 | 0.22 | 0.02 | 0.02 |
| (0.23-0.32) | (0.24-0.35) | (0.19-0.24) | (0.14-0.24) | (0.21-0.45) | (0.16-0.31) | (0.01-0.14) | (0.01-0.17) | |
| Diagnostic odds (95% CI) | 17 | 15 | 9 | 18 | 10 | 18 | 210 | 140 |
| (3.41-86.60) | (3.16-79.70) | (2.52-36.90) | (4.20-79.40) | (0.95-107) | (1.81-183) | (19.6-2240) | (13.90-1411) | |
| Diagnostic Accuracy (95% CI) | 78% | 77% | 83% | 84% | 76% | 81% | 95% | 95% |
| (68.30-85.60) | (66.90-84.80) | (73.60-89.60) | (74.10-90.40) | (63.8-86.28) | (72.80-87.20) | (88.20-98.10) | (88.20-98.10) | |
| Cohen’s Kappa (95% CI) | 0.41 | 0.39 | 0.40 | 0.49 | 0.24 | 0.36 | 0.79 | 0.72 |
| (0.22-0.60) | (0.20-0.58) | (0.19-0.61) | (0.28-0.69) | (0.03-0.45) | (0.13-0.58) | (0.57-1.00) | (0.52-0.94) | |
| P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
|
|
|
Patient is examined in the sitting position with the examiner in front of the patient. Elevate the patient’s chin ensuring the movement of patient’s larynx and trachea forward. This maneuver increases the prominence of the lateral lobes. With the neck in forward position, the chin is rotated slightly towards the side on which the lobe of the thyroid to be palpated, relaxing the ipsilateral sternocleidomastoid. Then using the pulp of the thumb against the lower lateral portion of the thyroid cartilage and upper two rings of trachea. The trachea is to be dislocated laterally with gentle pressure from opposite site as far as possible without causing choking. Then using the fingers of the opposite hand press deeply inward behind the sternomastoid and behind the thyroid lobe, and the thumb of that hand is brought over the anterior surface of the gland anterior to the sternomastoid. The dislocated lobe may then be palpated between the two. Patient is asked to swallow to confirm the palpated structure is thyroid. |
|
|
|
Patient is examined in the sitting position with the head resting on the clasped hands at the occiput. The patient is asked to push the head backwards. The examiner stands behind the patient to examine the gland. With the pulp of the index, middle and ring finger the lobes of the gland are palpated on both the sides followed by palpation of the isthmus. The flexion should be at the metacarpophalangeal joint and should not poke the patient. The patient is then asked to swallow to assess the lower border of the swelling as well as the retrosternal extension. This method is usually employed for examining obese patients with shorter neck as neck extension ensures better access to the thyroid gland. |
|
|
|
The patient is examined in the sitting position with head in normal position. The examiner stands in front of the patient. This method was described for small solitary thyroid swellings. Pulp of the thumb of the examiner is used to palpate the gland for any abnormality. The examiner uses his/her left thumb to palpate the left side of the gland and vice versa. The isthmus can be palpated with either hand of the examiner. Patient is asked to swallow to visualise the lower border and rule out retrosternal extension |
|
|
|
|
|
|
| |
|---|---|---|
| • Thyroid Swelling (Self detection, physician) | Yes/No | |
| • Palpable cervical lymph nodes | Yes/No | |
| • Dysphagia | Yes/No | |
| • Dysphonia | Yes/No | |
| • Dyspnoea | Yes/No | |
| • Pain | Yes/No | |
| • Others | Yes/No | |
| • History of any radiation exposure in past | Yes/No | |
| • History of thyroid malignancy in family | Yes/No |
|
| ||
|---|---|---|
| • Fatigue and lethargy | Yes/No | |
| • Muscular weakness | Yes/No | |
| • Weight gain | Yes/No | |
| • Constipation | Yes/No | |
| • Voice changes | Yes/No | |
| • Myxoedema | Yes/No | |
| • Cold intolerance | Yes/No |
|
|
| |
|---|---|---|
| • Insomnia | Yes/No | |
| • Diarrhoea | Yes/No | |
| • Palpitations | Yes/No | |
| • Heat intolerance | Yes/No | |
| • Sweating | Yes/No | |
| • Nervousness | Yes/No | |
| • Tremors | Yes/No | |
| • Vision changes | Yes/No | |
| • Hair loss | Yes/No |
|
|
|
|---|---|
|
| |
| Right lobe enlargement | Yes/No |
| Left lobe enlargement | Yes/No |
| Diffuse enlargement | Yes/No |
| Cervical Lymph node Enlargement | Yes/No |
| Retrosternal Extension | Yes/No |
| Tracheal Shift | Yes/No |
| Stridor on compression | Yes/No |
| Engorged neck veins | Yes/No |
| Size (by Vernier calliper) – | |
| Consistency – Soft/Firm/Hard | |
| Mobility – Mobile/Restricted/Fixed | |
|
| |
| Right lobe enlargement | Yes/No |
| Left lobe enlargement | Yes/No |
| Diffuse enlargement | Yes/No |
| Cervical Lymph node Enlargement | Yes/No |
| Retrosternal Extension | Yes/No |
| Tracheal Shift | Yes/No |
| Stridor on compression | Yes/No |
| Engorged neck veins | Yes/No |
| Size (by Vernier calliper) – | |
| Consistency – Soft/Firm/Hard | |
| Mobility – Mobile/Restricted/Fixed | |
|
| |
| Right lobe enlargement | Yes/No |
| Left lobe enlargement | Yes/No |
| Diffuse enlargement | Yes/No |
| Cervical Lymph node Enlargement | Yes/No |
| Retrosternal Extension | Yes/No |
| Tracheal Shift | Yes/No |
| Stridor on compression | Yes/No |
| Engorged neck veins | Yes/No |
| Size (by Vernier calliper) – | |
| Consistency – Soft/Firm/Hard | |
| Mobility – Mobile/Restricted/Fixed | |
|
| |
| Right lobe enlargement | Yes/No |
| Left lobe enlargement | Yes/No |
| Diffuse enlargement | Yes/No |
| Cervical Lymph node Enlargement | Yes/No |
| Retrosternal Extension | Yes/No |
| Tracheal Shift | Yes/No |
| Stridor on compression | Yes/No |
| Engorged neck veins | Yes/No |
| Size (by Vernier calliper) – | |
| Consistency – Soft/Firm/Hard | |
| Mobility – Mobile/Restricted/Fixed |